| ANG Lifesciences India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540694 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE236W01016 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 47.37 |
Market Cap(₹Cr) : 49.33 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 13.96 | 22.80 | 18.30 | 25.97 | 24.53 | 17.67 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 13.96 | 22.80 | 18.30 | 25.97 | 24.53 | 17.67 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.19 | 0.19 | 0.16 | 0.21 | 0.17 | 0.75 |
| Total Income | 14.15 | 22.99 | 18.46 | 26.18 | 24.71 | 18.42 |
| Total Expenditure | 15.42 | 18.18 | 20.38 | 23.75 | 22.68 | 18.03 |
| PBIDT | -1.27 | 4.81 | -1.92 | 2.42 | 2.03 | 0.39 |
| Interest | 1.77 | 1.65 | 1.61 | 1.59 | 1.61 | 2.05 |
| PBDT | -3.04 | 3.16 | -3.52 | 0.84 | 0.42 | -1.66 |
| Depreciation | 1.47 | 1.73 | 1.45 | 1.45 | 1.45 | 1.30 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.09 | 0.33 | -0.74 | 0.18 | -0.24 | -1.02 |
| Reported Profit After Tax | -3.42 | 1.10 | -4.24 | -0.80 | -0.79 | -1.94 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -3.42 | 1.10 | -4.24 | -0.80 | -0.79 | -1.94 |
| EPS (Unit Curr.) | -2.59 | 0.90 | -3.23 | -0.60 | -0.59 | -1.50 |
| EPS (Adj) (Unit Curr.) | -2.59 | 0.90 | -3.23 | -0.60 | -0.59 | -1.50 |
| Calculated EPS (Unit Curr.) | -2.62 | 0.84 | -3.25 | -0.61 | -0.60 | -1.48 |
| Calculated EPS (Adj) (Unit Curr.) | -2.62 | 0.84 | -3.25 | -0.61 | -0.60 | -1.48 |
| Calculated EPS (Ann.) (Unit Curr.) | -10.47 | 3.38 | -12.99 | -2.45 | -2.41 | -5.94 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -10.47 | 3.38 | -12.99 | -2.45 | -2.41 | -5.94 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.06 | 13.06 | 13.06 | 13.06 | 13.06 | 13.06 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -9.10 | 21.10 | -10.49 | 9.32 | 8.28 | 2.21 |
| PBDTM(%) | -21.78 | 13.86 | -19.23 | 3.23 | 1.71 | -9.39 |
| PATM(%) | -24.50 | 4.82 | -23.17 | -3.08 | -3.22 | -10.98 |
